Literature DB >> 2157919

[Malaria tropica with activation of blood coagulation and detection of tumor necrosis factor (NF-alpha) in serum].

C J Hemmer1, P Kern, K P Radtke, R E Egbring, P P Nawroth, M Dietrich.   

Abstract

A 38-year-old patient with cerebral P. falciparum malaria was admitted 12 days after a short trip to Kenya. The serum level of tumor necrosis factor (TNF-alpha) was elevated (251 pg/ml). In contrast, Protein C (plasma activity 36.1%; antigen concentration 31.7%) and protein C inhibitor 1 (activity 0.55 U/ml) levels were decreased. This suggested a state of functional activation of the clotting system which was confirmed by elevated levels (4.8 ng/ml) of circulating thrombin-antithrombin-III-complexes (TAT). Protein S (total and free) and coagulation factor IX levels were within normal range. Under successful antiparasitic therapy, TNF-alpha as well as protein C and protein C inhibitor 1 levels returned to baseline within one week. In the context of other studies that demonstrate procoagulant effects of TNF-alpha, it is remarkable that in the case of complicated P. falciparum malaria, an elevated concentration of TNF-alpha can be paralleled by a decreased plasma level of protein C and an increase in TAT suggesting a procoagulant state.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2157919     DOI: 10.1007/BF02116058

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  28 in total

1.  Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.

Authors:  F B Taylor; A Chang; C T Esmon; A D'Angelo; S Vigano-D'Angelo; K E Blick
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

2.  Recombinant tumour necrosis factor inhibits malaria parasites in vivo but not in vitro.

Authors:  J Taverne; J Tavernier; W Fiers; J H Playfair
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

3.  Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria.

Authors:  P Kern; C J Hemmer; J Van Damme; H J Gruss; M Dietrich
Journal:  Am J Med       Date:  1989-08       Impact factor: 4.965

Review 4.  Interleukin-1.

Authors:  C A Dinarello
Journal:  Rev Infect Dis       Date:  1984 Jan-Feb

5.  Platelet secretory activities in acute malaria (Plasmodium falciparum) infection.

Authors:  E M Essien; M I Ebhota
Journal:  Acta Haematol       Date:  1983       Impact factor: 2.195

6.  An abnormal plasma distribution of protein S occurs in functional protein S deficiency.

Authors:  P C Comp; D Doray; D Patton; C T Esmon
Journal:  Blood       Date:  1986-02       Impact factor: 22.113

7.  Malaria-induced thrombocytopenia.

Authors:  R D Horstmann; M Dietrich; U Bienzle; H Rasche
Journal:  Blut       Date:  1981-03

8.  Inhibition of human megakaryocytopoiesis in vitro by platelet factor 4 (PF4) and a synthetic COOH-terminal PF4 peptide.

Authors:  A M Gewirtz; B Calabretta; B Rucinski; S Niewiarowski; W Y Xu
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

9.  Platelet hypersensitivity in acute malaria (Plasmodium falciparum) infection in man.

Authors:  E M Essien; M I Ebhota
Journal:  Thromb Haemost       Date:  1981-08-28       Impact factor: 5.249

10.  Modulation of endothelial cell hemostatic properties by tumor necrosis factor.

Authors:  P P Nawroth; D M Stern
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.